Category: pharma & healthcare

The British government’s decision to forego a more rigorous approval process for Covid-19 vaccines has received criticism from EU regulators—and rightly so.

The CDC left quarantine decisions to the isolated individual’s preference, which will lead to unnecessary transmission and a longer pandemic.

In 2019, Scott Gottlieb, former Food and Drug Administration (FDA) commissioner, argued against throwing in the towel on biosimilars, as some other experts had advised. Gottlieb was right. The growth in biosimilar market share from late 2018 until now …

From frozen food to contaminated freight, some ways of spreading Covid-19 go unnoticed in countries where disease surveillance is crippled by a constant influx of new cases. That doesn’t mean they’re inconsequential.

Pfizer and Moderna have created a Lamborghini when what most countries really need is a Toyota—a vaccine that can be manufactured, stored, and administered simply and cheaply.

By demanding that the government justify gathering size limits at religious services based on public health, the French Council of State is appealing to reason and compromise; ensure non-discriminatory application of public health measures and the use …

Since the launch of Operation Warp Speed, data on vaccines has been released first by the drugmakers themselves and only later is the full data published. As a vaccine moves closer to reality, this needs to change.

In September, a man who had tested negative for Covid-19 boarded a flight. Days later, he and six other passengers were confirmed to be infected. The risks of air travel are real and, with the holidays fast approaching, must be taken into account.